Liang XK, Li LJ, He YM, Xu ZF. Misdiagnosis of pancreatic metastasis from renal cell carcinoma: A case report. World J Clin Cases 2022; 10(25): 9012-9019 [PMID: 36157676 DOI: 10.12998/wjcc.v10.i25.9012]
Corresponding Author of This Article
Zuo-Feng Xu, PhD, Chief Physician, Department of Medical Ultrasonics, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, Guangming District, Shenzhen 518107, Guangdong Province, China. xuzuofeng77@aliyun.com
Research Domain of This Article
Gastroenterology & Hepatology
Article-Type of This Article
Case Report
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Xuan-Kun Liang, Lu-Jing Li, Ye-Mei He, Zuo-Feng Xu, Department of Medical Ultrasonics, The Seventh Affiliated Hospital of Sun Yat-sen University, Shenzhen 518107, Guangdong Province, China
Author contributions: Liang XK investigated all the clinical data of the patient, reviewed the literature and contributed to manuscript drafting; Li LJ performed the microbiological analyses and interpretation and contributed to manuscript drafting; He YM analyzed and interpreted the imaging findings; Xu ZF was responsible for EUS and biopsy, and was responsible for the revision of the manuscript for important intellectual content; all authors issued final approval for the version to be submitted.
Informed consent statement: Informed written consent was obtained from the patient for publication of this report and any accompanying images.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
CARE Checklist (2016) statement: The authors have read the CARE Checklist (2016), and the manuscript was prepared and revised according to the CARE Checklist (2016).
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zuo-Feng Xu, PhD, Chief Physician, Department of Medical Ultrasonics, The Seventh Affiliated Hospital of Sun Yat-sen University, No. 628 Zhenyuan Road, Guangming District, Shenzhen 518107, Guangdong Province, China. xuzuofeng77@aliyun.com
Received: March 16, 2022 Peer-review started: March 16, 2022 First decision: May 30, 2022 Revised: June 13, 2022 Accepted: July 21, 2022 Article in press: July 21, 2022 Published online: September 6, 2022 Processing time: 162 Days and 17.5 Hours
Core Tip
Core Tip: Pancreatic metastases derived from clear cell renal cell carcinoma are rare and can be maintained for a long time and progress until years later. It is easily confused with hypervascular tumors, such as pancreatic neuroendocrine tumors (pNET). We present a case of a pancreatic mass that had undergone nephrectomy 19 years ago. Due to the lack of medical records, the clinical and imaging findings were misdiagnosed as pNET due to a false medical history. Preoperative biopsy was performed prudently, resulting in a renal-derived tumor, consistent with the findings of the pathological section obtained from the previous surgery hospital. This case highlights the importance of accurate clinical data, especially with a history of surgery, even a long time ago.
